Environmental Analysis of Therapeutic hMSC Manufacturing: A Comparison of Multiple Bioprocess Systems June 08, 2021 Biomanufacturing, Quality & Regulatory
Identify & Define Your Cell Therapy’s Biomanufacturing Approach for Critical Process… April 27, 2021 Biomanufacturing, Quality & Regulatory
Critical Quality Attributes (CQAs): Know Their Importance & Limitations in Product & Process… April 27, 2021 Biomanufacturing, Quality & Regulatory
“Known Unknowns” Affect Critical Process Parameters & Critical Quality Attributes in the… April 22, 2021 Biomanufacturing, Quality & Regulatory
Building Effective Multi-Year Process Development Programs II: Evolution of Technology Platform Decisions… March 30, 2021 BioEconomy, Biomanufacturing, Bioprocess Tools, Cell Therapy
Building Effective Multi-Year Process Development Programs I: Estimating hMSC Lot Size Ranges for… March 16, 2021 BioEconomy, Biomanufacturing, Bioprocess Tools, Cell Therapy
MSC KOL Interview: Tackling MSC EV Drug Delivery & Biomanufacturing Challenges with Steven Jay January 20, 2021 EVs & Exosomes
Know Your Cost of Goods Recap and Managing Lot Size Estimation November 02, 2020 Cell Therapy, MSCs & Characterization
Final Product Containers for Cell Therapies August 21, 2020 Biomanufacturing, Bioprocess Tools, Cell Therapy
